<qa>  What is the purpose of a Phase 3 Randomized, Double-blind, PlacebA Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial with an Open-label Extension to evaluate the efficacy of bremelanotide BMT, administered subcutaneously SC on an as needed basis for the treatment of HSDD with or without decreased arousal in premenopausal females. 